Doxorubicin (DOX), a quinone-containing anthracycline antineoplastic, is used for the treatment of solid and hematopoietic tumors. However, its dose-dependent cardiotoxicity hampered its clinical application.1) Recent studies have suggested that DOX-induced cardiotoxicity involves the formation of reactive oxygen species (ROS) and amplification of mitochondrial dysfunction.1,2) Moreover, the anticancer effects of DOX do not follow the identical mechanisms of ROS. The majority of strategies to protect cardiomyocytes against DOX-induced oxidative injury in heart therefore focused on administering antioxidants in the past.
1)A number of antioxidants, such as lycopene, N-acetylcysteine and vitamin E were proved to ameliorate the DOXinduced cardiac cell damage without compromising its antitumor efficacy in the rats or mice model. [3][4][5] However, most of them were tried with limited success in preventing DOX-associated cardiotoxicity in large-sized animals such as dogs or pigs.
6)Lycium barbarum, a famous Chinese medicinal herb, has a long history of use as an antioxidant and to promote sexual fertility. Lycium barbarum polysaccharides (LBP), consisting of various botanic polysaccharide including arabinose, rhamnose, xylose, mannose, galactose and glucose, are the most important functional constituents in red-colored fruits Lycium barbarum. LBP and edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one, a potent free radical scavenger, EDA) were found to elicit a typical cardioprotective effect against DOXrelated oxidative stress in rats. 7,8) However, no similar cardioprotective effect of either LBP or EDA was reported in beagle dogs. Electrocardiography (ECG) is one of the standard methods used to assess cardiac function and is often performed to evaluate whether cardioprotective agents would improve DOX-induced conduction abnormalities.9,10) Moreover, the usefulness of biochemical indicators such as serum creatine kinase (CK) and aspartate aminotransferase (AST) in assessment of DOX-associated cardiotoxicity in experimental animals has also been indicated by various studies.
11)The present study aims to explore electrocardiographic and biochemical evidence for the cardioprotective effect of those two antioxidants in DOX-induced acute cardiotoxicity in beagle dogs.
MATERIALS AND METHODSChemicals DOX was obtained from Pfizer Italia S.r.l. (Nerviano, Italy) as a 10 mg/bottle lyophilized powder. It was dissolved in 20 ml of 0.9% saline for injection. Lycium Chinese mill Polysaccharide was purchased from Zhejiang Doxorubicin (DOX) is a potent antitumor agent, but the cardiotoxicity mediated by the formation of reactive oxygen species limit its clinical use. The present study aims to explore electrocardiographic and biochemical evidence for the cardioprotective effect of two antioxidants, Lycium barbarum polysaccharides (LBP, the main antioxidant in Lycium barbarum) and edaravone (a potent free radical scavenger, EDA) against DOX-induced acute cardiotoxicity in beagle dogs. In this study, male beagle dogs received daily treat...